Status: current, Defined. Date: 28-Feb 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4526911000168114 | L.C.E. 125/31.25/200 (carbidopa 31.25 mg + entacapone 200 mg + levodopa 125 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4526921000168119 | L.C.E. 125/31.25/200 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
L.C.E. 125/31.25/200 tablet, 10, bottle | has TPUU | True | L.C.E. 125/31.25/200 tablet | Inferred relationship | Some | 405910828 |
L.C.E. 125/31.25/200 tablet, 30, bottle | has TPUU | True | L.C.E. 125/31.25/200 tablet | Inferred relationship | Some | 438529552 |
L.C.E. 125/31.25/200 tablet, 10 | has TPUU | True | L.C.E. 125/31.25/200 tablet | Inferred relationship | Some | 2101708966 |
L.C.E. 125/31.25/200 tablet, 30 | has TPUU | True | L.C.E. 125/31.25/200 tablet | Inferred relationship | Some | 1977388147 |
L.C.E. 125/31.25/200 tablet, 100, bottle | has TPUU | True | L.C.E. 125/31.25/200 tablet | Inferred relationship | Some | 921707142 |
L.C.E. 125/31.25/200 tablet, 100 | has TPUU | True | L.C.E. 125/31.25/200 tablet | Inferred relationship | Some | 330133257 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product unit of use reference set